Ergomed Plc (LSE:ERGO) has announced the appointment of Stuart Jackson as the group’s chief financial officer with immediate effect.
The AIM-listed company, which is focused on providing specialised services to the pharmaceutical industry, said Jackson has “significant international experience in early stage and growth companies as well as managing significant and complex change projects.”
The group noted that he was chief financial officer at Acergy SA responsible for the financial restructuring of the business and implementation of the new business strategy which took Acergy from US$0.1bn to US$6.0bn market capitalisation over a four year period.
More recently it added, he was chief financial officer at CEONA, a Goldman Sachs Capital Partners group of companies, where he was responsible for the early stage set-up and growth of the business, and at Bibby Offshore Holdings Limited where, as chief financial officer, he also managed the strategic development and M&A activities and oversaw its recent recapitalisation.
Stephen Stamp, Ergomed’s chief executive officer of Ergomed commented: "Stuart brings to Ergomed a strong track record of delivery within project and service related businesses on an international scale.
“His experience in non-healthcare services businesses will provide a broader perspective to our project delivery and he will play an integral role in enhancing the strong foundations of Ergomed as we seek to deliver our strategy of taking a market leading position.”
In early morning trading, Ergomed shares were 3.9% higher at 187p.